Cheryl is a seasoned R&D leader with deep pharmaceutical, biotechnology, and CRO experience. She guides and directs the development of breakthrough therapies to improve the treatment of PF.

She has a rich background in pre-clinical and early clinical drug development of innovative medicines having held senior roles at Pfizer as Chief Operating Officer/Senior Director for the Department of Immunology and Autoimmunity and at Caprion/ImmuneCarta (now CellCarta), Biogen, and Bayer. In addition to drug development, she has a strong publication record covering the immune and inflammatory basis of disease.